179
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Age and multimorbidities as poor prognostic factors for COVID-19 in hemodialysis: a Lebanese national study

      research-article
      1 , 2 , , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 12 , 13 , 14 , 14 , 15 , 16 , 17 , 17 , 17 , 2 , 18 , 2 , 18 , 19 , 20 , 20 , 21 , 22 , 23 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 31 , 32 , 32 , 33 , 34 , 34 , 35 , 34 , 35 , 34 , 35 , 36 , 27 , 37 , 3 , 9 , 2 , 18 , 2 , 18
      BMC Nephrology
      BioMed Central
      COVID-19, Hemodialysis, Mortality, Multimorbidities, SARS-CoV-2, National study

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Hemodialysis patients with COVID-19 have been reported to be at higher risk for death than the general population. Several prognostic factors have been identified in the studies from Asian, European or American countries. This is the first national Lebanese study assessing the factors associated with SARS-CoV-2 mortality in hemodialysis patients.

          Methods

          This is an observational study that included all chronic hemodialysis patients in Lebanon who were tested positive for SARS-CoV-2 from 31st March to 1st November 2020. Data on demographics, comorbidities, admission to hospital and outcome were collected retrospectively from the patients’ medical records. A binary logistic regression analysis was performed to assess risk factors for mortality.

          Results

          A total of 231 patients were included. Mean age was 61.46 ± 13.99 years with a sex ratio of 128 males to 103 females. Around half of the patients were diabetics, 79.2% presented with fever. A total of 115 patients were admitted to the hospital, 59% of them within the first day of diagnosis. Hypoxia was the major reason for hospitalization. Death rate was 23.8% after a median duration of 6 (IQR, 2 to 10) days. Adjusted regression analysis showed a higher risk for death among older patients (odds ratio = 1.038; 95% confidence interval: 1.013, 1.065), patients with heart failure (odds ratio = 4.42; 95% confidence interval: 2.06, 9.49), coronary artery disease (odds ratio = 3.27; 95% confidence interval: 1.69, 6.30), multimorbidities (odds ratio = 1.593; 95% confidence interval: 1.247, 2.036), fever (odds ratio = 6.66; 95% confidence interval: 1.94, 27.81), CRP above 100 mg/L (odds ratio = 4.76; 95% confidence interval: 1.48, 15.30), and pneumonia (odds ratio = 19.18; 95% confidence interval: 6.47, 56.83).

          Conclusions

          This national study identified older age, coronary artery disease, heart failure, multimorbidities, fever and pneumonia as risk factors for death in patients with COVID-19 on chronic hemodialysis. The death rate was comparable to other countries and estimated at 23.8%.

          Related collections

          Most cited references14

          • Record: found
          • Abstract: found
          • Article: not found

          Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China

          Reports indicate that those most vulnerable to developing severe coronavirus disease 2019 (COVID-19) are older adults and those with underlying illnesses, such as diabetes mellitus, hypertension, or cardiovascular disease, which are common comorbidities among patients undergoing maintenance hemodialysis. However, there is limited information about the clinical characteristics of hemodialysis patients with COVID-19 or about interventions to control COVID-19 in hemodialysis centers.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found

            Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres

            Abstract COVID-19, a disease caused by a novel coronavirus, is a major global human threat that has turned into a pandemic. This novel coronavirus has specifically high morbidity in the elderly and in comorbid populations. Uraemic patients on dialysis combine an intrinsic fragility and a very frequent burden of comorbidities with a specific setting in which many patients are repeatedly treated in the same area (haemodialysis centres). Moreover, if infected, the intensity of dialysis requiring specialized resources and staff is further complicated by requirements for isolation, control and prevention, putting healthcare systems under exceptional additional strain. Therefore, all measures to slow if not to eradicate the pandemic and to control unmanageably high incidence rates must be taken very seriously. The aim of the present review of the European Dialysis (EUDIAL) Working Group of ERA-EDTA is to provide recommendations for the prevention, mitigation and containment in haemodialysis centres of the emerging COVID-19 pandemic. The management of patients on dialysis affected by COVID-19 must be carried out according to strict protocols to minimize the risk for other patients and personnel taking care of these patients. Measures of prevention, protection, screening, isolation and distribution have been shown to be efficient in similar settings. They are essential in the management of the pandemic and should be taken in the early stages of the disease.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Exposure to novel coronavirus in patients on renal replacement therapy during the exponential phase of COVID-19 pandemic: survey of the Italian Society of Nephrology

              Background Between February and April 2020, Italy experienced an overwhelming growth of the COVID-19 pandemic. Little is known, at the country level, where and how patients on renal replacement therapy (RRT) have been mostly affected. Methods Survey of the network of Nephrology centers using a simplified 17 items electronic questionnaire designed by Italian Society of Nephrology COVID-19 Research Group. We used spatial epidemiology and geographical information systems to map SARS-CoV-2 spread among RRT patients in Italy. Results On April 9th 2020, all nephrology centers (n = 454) listed in the DialMap database were invited to complete the electronic questionnaire. Within 11 days on average, 365 centers responded (80.4% response rate; 2.3% margin of error) totaling 60,441 RRT patients. The surveyed RRT population included 30,821 hemodialysis (HD), 4139 peritoneal dialysis (PD), and 25,481 transplanted (Tx) patients respectively. The proportion of SARS-CoV-2 positive RRT patients in Italy was 2.26% (95% CI 2.14–2.39) with significant differences according to treatment modality (p < 0.001). The proportion of patients positive for SARS-CoV-2 was significantly higher in HD (3.55% [95% CI 3.34–3.76]) than PD (1.38% [95% CI 1.04–1.78] and Tx (0.86% [95% CI 0.75–0.98]) (p < 0.001), with substantial heterogeneity across regions and along the latitude gradient (p < 0.001). In RRT patients the highest rate was in the north-west (4.39% [95% CI 4.11–4.68], followed by the north-east (IR 2.06% [1.79–2.36]), the center (0.91% [0.75–1.09]), the main islands (0.67% [0.47–0.93]), and the south (0.59% [0.45–0.75]. During the COVID-19 pandemic, among SARS-Cov-2 positive RRT patients the fatality rate was 32.8%, as compared to 13.3% observed in the Italian population as of April 23rd. Conclusions A substantial proportion of the 60,441 surveyed RRT patients in Italy were SARS-Cov-2 positive and subsequently died during the exponential phase of COVID-19 pandemic. Infection risk and rates seems to differ substantially across regions, along geographical latitude, and by treatment modality. Electronic supplementary material The online version of this article (10.1007/s40620-020-00794-1) contains supplementary material, which is available to authorized users.
                Bookmark

                Author and article information

                Contributors
                aounmabel@yahoo.fr
                rababkhalil97@gmail.com
                walidmahfoud1973@hotmail.com
                drfatfat@hotmail.com
                linebouyounes@hotmail.com
                rachad.alameddine@gmail.com
                afiouni_nabil@yahoo.fr
                ibrahimissam@hotmail.com
                mohamadhassan@outlook.com
                drhaithamzarzour@gmail.com
                alinephro@yahoo.com
                ninamouradkhalil@gmail.com
                dr.luaytawil@gmail.com
                zeina_mechref@hotmail.com
                GM@awmedicalvillage.org
                f_shamma@hotmail.com
                dr_akhalil@hotmail.com
                sandyzeidan@gmail.com
                balsamghoul@hotmail.com
                georges.dahdah@hotmail.com
                mouawad.sarah@gmail.com
                hibaazar@hotmail.com
                k.abouchahine@gmail.com
                sibakallab@hotmail.com
                bachir_maouad@hotmail.com
                drahmadfawaz@yahoo.com
                josephhomsi@hotmail.com
                karmen.tabaja@hotmail.com
                mayadelbany88@gmail.com
                ramikallab@hotmail.com
                hh100@aub.edu.lb
                dr_haykal76@hotmail.com
                n_joubran@hotmail.com
                drwalidrahal@hotmail.com
                mroueh_wael@hotmail.com
                dmhd.youssef@gmail.com
                jamale87@gmail.com
                ziadelsebaaly@hotmail.com
                antoine.dfouni@hotmail.com
                norma.ghosn@hotmail.com
                molnapalm@hotmail.com
                walid1md@yahoo.com
                n_bassil@hotmail.com
                theresemaroun@hotmail.com
                nabil.bassil@gmail.com
                shadiabeaini@hotmail.com
                drashmoun@gmail.com
                eliemoubarak@terra.net.lb
                dr.hrabah@gmail.com
                ornimar@hotmail.com
                serge-finianos@hotmail.com
                daniachelala@hotmail.com
                Journal
                BMC Nephrol
                BMC Nephrol
                BMC Nephrology
                BioMed Central (London )
                1471-2369
                27 February 2021
                27 February 2021
                2021
                : 22
                : 73
                Affiliations
                [1 ]GRID grid.416659.9, ISNI 0000 0004 1773 3761, Department of Nephrology, , Saint-George Hospital Ajaltoun, ; Ajaltoun, Lebanon
                [2 ]GRID grid.42271.32, ISNI 0000 0001 2149 479X, Faculty of Medicine, , Saint-Joseph University, ; Beirut, Lebanon
                [3 ]GRID grid.416324.6, ISNI 0000 0004 0571 327X, Makassed General Hospital, ; Beirut, Lebanon
                [4 ]Saydet Zghorta Hospital, Zgharta, Lebanon
                [5 ]Mounla Hospital, Tripoli, Lebanon
                [6 ]Mount-Lebanon Hospital, Hazmiyeh, Lebanon
                [7 ]Orange Nassau Hospital, Tripoli, Lebanon
                [8 ]Islamic Hospital, Tripoli, Lebanon
                [9 ]Youssef Akkar Hospital, Halba, Lebanon
                [10 ]Dar Al-Chifae Hospital, Tripoli, Lebanon
                [11 ]Zahraa Hospital, Jnah, Lebanon
                [12 ]Bahman Hospital, Beirut, Lebanon
                [13 ]Siblin Governmental Hospital, Sebline, Lebanon
                [14 ]Ain Wazein Medical Village, Ain Wazein, Lebanon
                [15 ]Serhal Hospital, Beirut, Lebanon
                [16 ]Iklim Hospital, Mazboud, Lebanon
                [17 ]Centre Hospitalier du Nord, Zghorta, Lebanon
                [18 ]GRID grid.413559.f, ISNI 0000 0004 0571 2680, Hotel-Dieu de France Hospital, ; Beirut, Lebanon
                [19 ]Beqaa Hospital, Zahlé, Lebanon
                [20 ]Abou Jaoude Hospital, Jal el Dib, Lebanon
                [21 ]Labib Hospital, Sidon, Lebanon
                [22 ]Khoury Hospital, Zahle, Lebanon
                [23 ]GRID grid.477313.5, ISNI 0000 0004 0622 8161, Hammoud Hospital University Medical Center, ; Sidon, Lebanon
                [24 ]FMC Hospital, Mejdlaya, Lebanon
                [25 ]Sahel Hospital, Haret Hreik, Lebanon
                [26 ]Beit Chabeb Hospital, Beit Chabeb, Lebanon
                [27 ]Saint-Georges Orthodoxe Hospital, Beirut, Lebanon
                [28 ]Rahal Hospital, Akkar, Lebanon
                [29 ]Jabal Amel Hospital, Tyre, Lebanon
                [30 ]Dinnieh Hospital, Dinnieh, Lebanon
                [31 ]Haroun Hospital, Zalka, Lebanon
                [32 ]GRID grid.448775.d, Centre Hospitalier Universitaire Notre Dame de Secours Hospital, ; Byblos, Lebanon
                [33 ]Sacre-Coeur Hospital, Baabda, Lebanon
                [34 ]Middle-East Institute of Health, Bsalim, Lebanon
                [35 ]Saint-Joseph Hospital, Dora, Lebanon
                [36 ]Bellevue Medical Center, Mansourieh, Lebanon
                [37 ]Hayek Hospital, Al Hayek, Lebanon
                Article
                2270
                10.1186/s12882-021-02270-9
                7912967
                33639881
                abc5acfe-4d9c-4add-b17f-14632cc2370d
                © The Author(s) 2021

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 9 December 2020
                : 16 February 2021
                Categories
                Research Article
                Custom metadata
                © The Author(s) 2021

                Nephrology
                covid-19,hemodialysis,mortality,multimorbidities,sars-cov-2,national study
                Nephrology
                covid-19, hemodialysis, mortality, multimorbidities, sars-cov-2, national study

                Comments

                Comment on this article